Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT

Shreya Mitra, Lorenzo Federico, Wei Zhao, Jennifer Dennison, Tapasree Roy Sarkar, Fan Zhang, Vinita Takiar, Kwai W. Cheng, Sendurai Mani, Ju Seog Lee, Gordon Mills

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The Rab GTPases regulate vesicular trafficking machinery that transports and delivers a diverse pool of cargo, including growth factor receptors, integrins, nutrient receptors and junction proteins to specific intracellular sites. The trafficking machinery is indeed a major posttranslational modifier and is critical for cellular homeostasis. Deregulation of this stringently controlled system leads to a wide spectrum of disorders including cancer. Herein we demonstrate that Rab25, a key GTPase, mostly decorating the apical recycling endosome, is a dichotomous variable in breast cancer cell lines with higher mRNA and protein expression in Estrogen Receptor positive (ER+ve) lines. Rab25 and its effector, Rab Coupling Protein (RCP) are frequently coamplified and coordinately elevated in ER+ve breast cancers. In contrast, Rab25 levels are decreased in basal-like and almost completely lost in claudin-low tumors. This dichotomy exists despite the presence of the 1q amplicon that hosts Rab25 across breast cancer subtypes and is likely due to differential methylation of the Rab25 promoter. Functionally, elevated levels of Rab25 drive major hallmarks of cancer including indefinite growth and metastasis but in case of luminal B breast cancer only. Importantly, in such ER+ve tumors, coexpression of Rab25 and its effector, RCP is significantly associated with a markedly worsened clinical outcome. Importantly, in claudin-low cell lines, exogenous Rab25 markedly inhibits cell migration. Similarly, during Snail-induced epithelial to mesenchymal transition (EMT) exogenous Rab25 potently reverses Snail-driven invasion. Overall, this study substantiates a striking context dependent role of Rab25 in breast cancer where Rab25 is amplified and enhances aggressiveness in luminal B cancers while in claudin-low tumors, Rab25 is lost indicating possible anti-tumor functions.

Original languageEnglish (US)
Pages (from-to)40252-40265
Number of pages14
JournalOncotarget
Volume7
Issue number26
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Epithelial-Mesenchymal Transition
Oncogenes
Breast Neoplasms
Neoplasms
Proteins
rab GTP-Binding Proteins
Cell Line
Growth Factor Receptors
Endosomes
GTP Phosphohydrolases
Integrins
Estrogen Receptors
Methylation
Cell Movement
Homeostasis
Neoplasm Metastasis
Food
Messenger RNA
Growth

Keywords

  • Breast cancer
  • Claudin low
  • Luminal B
  • Rab coupling protein
  • Rab25

ASJC Scopus subject areas

  • Oncology

Cite this

Mitra, S., Federico, L., Zhao, W., Dennison, J., Sarkar, T. R., Zhang, F., ... Mills, G. (2016). Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT. Oncotarget, 7(26), 40252-40265.

Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT. / Mitra, Shreya; Federico, Lorenzo; Zhao, Wei; Dennison, Jennifer; Sarkar, Tapasree Roy; Zhang, Fan; Takiar, Vinita; Cheng, Kwai W.; Mani, Sendurai; Lee, Ju Seog; Mills, Gordon.

In: Oncotarget, Vol. 7, No. 26, 01.01.2016, p. 40252-40265.

Research output: Contribution to journalArticle

Mitra, S, Federico, L, Zhao, W, Dennison, J, Sarkar, TR, Zhang, F, Takiar, V, Cheng, KW, Mani, S, Lee, JS & Mills, G 2016, 'Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT', Oncotarget, vol. 7, no. 26, pp. 40252-40265.
Mitra S, Federico L, Zhao W, Dennison J, Sarkar TR, Zhang F et al. Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT. Oncotarget. 2016 Jan 1;7(26):40252-40265.
Mitra, Shreya ; Federico, Lorenzo ; Zhao, Wei ; Dennison, Jennifer ; Sarkar, Tapasree Roy ; Zhang, Fan ; Takiar, Vinita ; Cheng, Kwai W. ; Mani, Sendurai ; Lee, Ju Seog ; Mills, Gordon. / Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT. In: Oncotarget. 2016 ; Vol. 7, No. 26. pp. 40252-40265.
@article{99a2c081747d4a3291479ff16c1de57f,
title = "Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT",
abstract = "The Rab GTPases regulate vesicular trafficking machinery that transports and delivers a diverse pool of cargo, including growth factor receptors, integrins, nutrient receptors and junction proteins to specific intracellular sites. The trafficking machinery is indeed a major posttranslational modifier and is critical for cellular homeostasis. Deregulation of this stringently controlled system leads to a wide spectrum of disorders including cancer. Herein we demonstrate that Rab25, a key GTPase, mostly decorating the apical recycling endosome, is a dichotomous variable in breast cancer cell lines with higher mRNA and protein expression in Estrogen Receptor positive (ER+ve) lines. Rab25 and its effector, Rab Coupling Protein (RCP) are frequently coamplified and coordinately elevated in ER+ve breast cancers. In contrast, Rab25 levels are decreased in basal-like and almost completely lost in claudin-low tumors. This dichotomy exists despite the presence of the 1q amplicon that hosts Rab25 across breast cancer subtypes and is likely due to differential methylation of the Rab25 promoter. Functionally, elevated levels of Rab25 drive major hallmarks of cancer including indefinite growth and metastasis but in case of luminal B breast cancer only. Importantly, in such ER+ve tumors, coexpression of Rab25 and its effector, RCP is significantly associated with a markedly worsened clinical outcome. Importantly, in claudin-low cell lines, exogenous Rab25 markedly inhibits cell migration. Similarly, during Snail-induced epithelial to mesenchymal transition (EMT) exogenous Rab25 potently reverses Snail-driven invasion. Overall, this study substantiates a striking context dependent role of Rab25 in breast cancer where Rab25 is amplified and enhances aggressiveness in luminal B cancers while in claudin-low tumors, Rab25 is lost indicating possible anti-tumor functions.",
keywords = "Breast cancer, Claudin low, Luminal B, Rab coupling protein, Rab25",
author = "Shreya Mitra and Lorenzo Federico and Wei Zhao and Jennifer Dennison and Sarkar, {Tapasree Roy} and Fan Zhang and Vinita Takiar and Cheng, {Kwai W.} and Sendurai Mani and Lee, {Ju Seog} and Gordon Mills",
year = "2016",
month = "1",
day = "1",
language = "English (US)",
volume = "7",
pages = "40252--40265",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "26",

}

TY - JOUR

T1 - Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT

AU - Mitra, Shreya

AU - Federico, Lorenzo

AU - Zhao, Wei

AU - Dennison, Jennifer

AU - Sarkar, Tapasree Roy

AU - Zhang, Fan

AU - Takiar, Vinita

AU - Cheng, Kwai W.

AU - Mani, Sendurai

AU - Lee, Ju Seog

AU - Mills, Gordon

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The Rab GTPases regulate vesicular trafficking machinery that transports and delivers a diverse pool of cargo, including growth factor receptors, integrins, nutrient receptors and junction proteins to specific intracellular sites. The trafficking machinery is indeed a major posttranslational modifier and is critical for cellular homeostasis. Deregulation of this stringently controlled system leads to a wide spectrum of disorders including cancer. Herein we demonstrate that Rab25, a key GTPase, mostly decorating the apical recycling endosome, is a dichotomous variable in breast cancer cell lines with higher mRNA and protein expression in Estrogen Receptor positive (ER+ve) lines. Rab25 and its effector, Rab Coupling Protein (RCP) are frequently coamplified and coordinately elevated in ER+ve breast cancers. In contrast, Rab25 levels are decreased in basal-like and almost completely lost in claudin-low tumors. This dichotomy exists despite the presence of the 1q amplicon that hosts Rab25 across breast cancer subtypes and is likely due to differential methylation of the Rab25 promoter. Functionally, elevated levels of Rab25 drive major hallmarks of cancer including indefinite growth and metastasis but in case of luminal B breast cancer only. Importantly, in such ER+ve tumors, coexpression of Rab25 and its effector, RCP is significantly associated with a markedly worsened clinical outcome. Importantly, in claudin-low cell lines, exogenous Rab25 markedly inhibits cell migration. Similarly, during Snail-induced epithelial to mesenchymal transition (EMT) exogenous Rab25 potently reverses Snail-driven invasion. Overall, this study substantiates a striking context dependent role of Rab25 in breast cancer where Rab25 is amplified and enhances aggressiveness in luminal B cancers while in claudin-low tumors, Rab25 is lost indicating possible anti-tumor functions.

AB - The Rab GTPases regulate vesicular trafficking machinery that transports and delivers a diverse pool of cargo, including growth factor receptors, integrins, nutrient receptors and junction proteins to specific intracellular sites. The trafficking machinery is indeed a major posttranslational modifier and is critical for cellular homeostasis. Deregulation of this stringently controlled system leads to a wide spectrum of disorders including cancer. Herein we demonstrate that Rab25, a key GTPase, mostly decorating the apical recycling endosome, is a dichotomous variable in breast cancer cell lines with higher mRNA and protein expression in Estrogen Receptor positive (ER+ve) lines. Rab25 and its effector, Rab Coupling Protein (RCP) are frequently coamplified and coordinately elevated in ER+ve breast cancers. In contrast, Rab25 levels are decreased in basal-like and almost completely lost in claudin-low tumors. This dichotomy exists despite the presence of the 1q amplicon that hosts Rab25 across breast cancer subtypes and is likely due to differential methylation of the Rab25 promoter. Functionally, elevated levels of Rab25 drive major hallmarks of cancer including indefinite growth and metastasis but in case of luminal B breast cancer only. Importantly, in such ER+ve tumors, coexpression of Rab25 and its effector, RCP is significantly associated with a markedly worsened clinical outcome. Importantly, in claudin-low cell lines, exogenous Rab25 markedly inhibits cell migration. Similarly, during Snail-induced epithelial to mesenchymal transition (EMT) exogenous Rab25 potently reverses Snail-driven invasion. Overall, this study substantiates a striking context dependent role of Rab25 in breast cancer where Rab25 is amplified and enhances aggressiveness in luminal B cancers while in claudin-low tumors, Rab25 is lost indicating possible anti-tumor functions.

KW - Breast cancer

KW - Claudin low

KW - Luminal B

KW - Rab coupling protein

KW - Rab25

UR - http://www.scopus.com/inward/record.url?scp=84982972155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982972155&partnerID=8YFLogxK

M3 - Article

C2 - 27259233

AN - SCOPUS:84982972155

VL - 7

SP - 40252

EP - 40265

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 26

ER -